Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"WHO International Clinical Trials Registry Platform"
topic_facet:"Recruitment Status: Authorised-recruitment may be ongoing or finished"
topic_facet:"Medical Condition: Psoriatic arthritis MedDRA version: 21.0Level: LLTClassification code 10037160Term: Psoriatic arthritisSystem Organ Class: 100000004859;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Psoriatic+arthritis+MedDRA+version%3A+21.0Level%3A+LLTClassification+code+10037160Term%3A+Psoriatic+arthritisSystem+Organ+Class%3A+100000004859%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Skin+and+Connective+Tissue+Diseases+%5BC17%5D%22&lookfor=%22Arthritis%22&type=AllFields
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Psoriatic+arthritis+MedDRA+version%3A+21.0Level%3A+LLTClassification+code+10037160Term%3A+Psoriatic+arthritisSystem+Organ+Class%3A+100000004859%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Skin+and+Connective+Tissue+Diseases+%5BC17%5D%22&lookfor=%22Arthritis%22&type=AllFields
Search /vufind/Search2/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Psoriatic+arthritis+MedDRA+version%3A+21.0Level%3A+LLTClassification+code+10037160Term%3A+Psoriatic+arthritisSystem+Organ+Class%3A+100000004859%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Skin+and+Connective+Tissue+Diseases+%5BC17%5D%22&lookfor=%22Arthritis%22&type=AllFields
PubPharm (20)
1
A Study Comparing Risankizumab to Placebo in Subjects with Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(ies) : A Phase 3, Randomized, Double-Blind Study Comparing Risankizumab to Placebo in Subjects with Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or intolerance to Biologic Therapy(ies) (KEEPsAKE 2)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
2
A Study Comparing Risankizumab to Placebo in Subjects with Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(ies) : A Phase 3, Randomized, Double-Blind Study Comparing Risankizumab to Placebo in Subjects with Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or intolerance to Biologic Therapy(ies) (KEEPsAKE 2)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
3
A Study Comparing Risankizumab to Placebo in Subjects with Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(ies) (KEEPsAKE 2) : A Phase 3, Randomized, Double-Blind Study Comparing Risankizumab to Placebo in Subjects with Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or intolerance to Biologic Therapy(ies) (KEEPsAKE 2) - KEEPsAKE 2
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
4
A Study Comparing Risankizumab to Placebo in Subjects with Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(ies) : A Phase 3, Randomized, Double-Blind Study Comparing Risankizumab to Placebo in Subjects with Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or intolerance to Biologic Therapy(ies) - na
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
5
A Study Comparing Risankizumab to Placebo in Subjects with Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(ies) (KEEPsAKE 2) : A Phase 3, Randomized, Double-Blind Study Comparing Risankizumab to Placebo in Subjects with Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or intolerance to Biologic Therapy(ies) (KEEPsAKE 2) - KEEPsAKE 2
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
6
A Study Comparing Risankizumab to Placebo in Subjects with Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(ies) : A Phase 3, Randomized, Double-Blind Study Comparing Risankizumab to Placebo in Subjects with Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or intolerance to Biologic Therapy(ies) - na
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
7
Effects of abatacept on bones and bones marker of patients with psoriatic arthritis : Abatacept Bone Effects in Psoriatic Arthritis with Bone Biomarker – ABEPSA_BB - ABEPSA_BB
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
8
Effects of abatacept on bones and bones marker of patients with psoriatic arthritis : Abatacept Bone Effects in Psoriatic Arthritis with Bone Biomarker – ABEPSA_BB - ABEPSA_BB
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
9
A Study Comparing Risankizumab to Placebo in Subjects with Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(ies) (KEEPsAKE 2) : A Phase 3, Randomized, Double-Blind Study Comparing Risankizumab to Placebo in Subjects with Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or intolerance to Biologic Therapy(ies) (KEEPsAKE 2)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
10
A Study Comparing Risankizumab to Placebo in Subjects with Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(ies) (KEEPsAKE 2) : A Phase 3, Randomized, Double-Blind Study Comparing Risankizumab to Placebo in Subjects with Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or intolerance to Biologic Therapy(ies) (KEEPsAKE 2)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Zeitschrift: WHO International Clinical Trials Registry Platform
Filter aufheben
Thema: Recruitment Status: Authorised-recruitment may be ongoing or finished
Filter aufheben
Thema: Medical Condition: Psoriatic arthritis MedDRA version: 21.0Level: LLTClassification code 10037160Term: Psoriatic arthritisSystem Organ Class: 100000004859;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
Medienart
20
Aufsätze
20
E-Artikel
20
E-Ressourcen
Zeitschriftentitel
WHO International Clinical Trials Registry Plat...
Thema
20
610
Medical Condition: Psoriatic arthritis MedDRA v...
Recruitment Status: Authorised-recruitment may ...
20
Study Type: Interventional
16
Phase: Phase 3
2
Phase: Phase 2
2
Phase: Phase 4
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2
2022
6
2021
12
2020
Erscheinungsjahr(e)
Von:
Bis:
Sprache
20
Englisch
Haven't found what you're looking for?
Wird geladen...